Current evidence and the international advisory on the use of ibuprofen

Current evidence and the international advisory on the use of ibuprofen

General Practice
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 20 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 02 Nov 2021 

Overview

The efficacy, safety and cost-effectiveness of ibuprofen are well established.Ibuprofen is listed as an 'Essential Medicine' by the World Health Organisation (WHO). The recent outbreak of COVID-19 has raised concerns about the potential harm from the use of ibuprofen. 

This module provides updated information to help participants to gain a better understanding of:
• Gastrointestinal and cardiovascular effects and the safety of ibuprofen
• Efficacy of ibuprofen and the newer analgesic agents
• Safety of ibuprofen in patients with COVID-19
• Recommendations for ibuprofen in patients with COVID-19

CPD Reviewer: 

Dr Soo Chun Ian
Specialist (Internal & Respiratory Medicine)
Hospital Cancelor Tuanku Muhriz
Pusat Perubatan UKM
Kuala Lumpur


NOTE :
Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points. 

The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browsermay be required to view the modules. 

Sponsored by:

RB Health_logo.jpg